Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

BioCorRx (BICX) Receivables - Net (2016 - 2025)

BioCorRx's Receivables - Net history spans 16 years, with the latest figure at $194442.0 for Q3 2025.

  • For Q3 2025, Receivables - Net fell 38.11% year-over-year to $194442.0; the TTM value through Sep 2025 reached $194442.0, down 38.11%, while the annual FY2023 figure was $76266.0, 41.4% down from the prior year.
  • Receivables - Net for Q3 2025 was $194442.0 at BioCorRx, up from $51242.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $314170.0 in Q3 2024 and bottomed at $12215.0 in Q3 2023.
  • The 5-year median for Receivables - Net is $74022.5 (2023), against an average of $98139.7.
  • The largest annual shift saw Receivables - Net skyrocketed 11171.8% in 2021 before it tumbled 87.71% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $56359.0 in 2021, then surged by 130.93% to $130152.0 in 2022, then plummeted by 41.4% to $76266.0 in 2023, then soared by 311.94% to $314170.0 in 2024, then tumbled by 38.11% to $194442.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Receivables - Net are $194442.0 (Q3 2025), $51242.0 (Q2 2025), and $111966.0 (Q1 2025).